Canada’s Shoppers Drug Mart posts Q4 results
TORONTO — Canadian pharmacy retailer Shoppers Drug Mart posted an increase in fourth-quarter sales driven by gains at the front end and strength in prescription count growth. The company also noted that it is gearing up for an expansion of its enhanced beautyBOUTIQUE during 2014.
Sales for the quarter were Canadian $2.75 billion, an increase of 0.9% compared with the year-ago period. Same-store sales increased 1.2% during the quarter.
Pharmacy sales were C$1.23 billion in the fourth quarter, an increase of 0.8% compared with the same period of the prior year, as strong growth in the number of prescriptions filled at retail was partially offset by a further reduction in average prescription value, the company stated. On a same-store basis, pharmacy sales increased 0.5%.
During the fourth quarter of 2013, the number of prescriptions dispensed at retail increased 5% compared with the same period of the prior year and was up 4.7% on a same-store basis. Pharmacy volume growth was evident in all regions of the country and remains particularly strong in Ontario, the company noted.
Year-over-year, average prescription value at retail declined a further 3.8% during the fourth quarter of 2013, largely the result of further reductions in generic prescription reimbursement rates because of ongoing drug system reform initiatives in all provincial jurisdictions, along with increasing generic prescription utilization rates.
Front store sales were C$1.517 billion in the fourth quarter, an increase of 1.1% compared with the year-ago period, led by strong growth in cosmetics and food and confection. This is a particularly strong result relative to the marketplace and given that sales of OTC medications declined year-over-year in the absence of a strong cough and cold season compared with the fourth quarter of last year, the company stated. On a same-store basis, front store sales increased 1.7%.
Net earnings, inclusive of transaction-related costs of C$3 million associated with the pending acquisition of the company by Loblaw, were C$169 million in the quarter. Excluding the impact of these costs, adjusted net earnings for the fourth quarter of 2013 were C$172 million compared with net earnings of C$175 million in the same period of the prior year. On a diluted basis, adjusted net earnings per share were 86 Canadian cents in the fourth quarter of 2013 compared with net earnings per share of 85 Canadian cents in the same period of the prior year, an increase of 1.2%.
"We are pleased with our fourth quarter and full year operating and financial results. By any measure, our performance in the fourth quarter of 2013 is a successful conclusion to what has been a very successful year for our company and its shareholders. In what remains a highly competitive and challenging marketplace, it is clear that our value proposition and unwavering commitment to provide the best in patient-care and customer service continues to resonate with patients and customers alike," Domenic Pilla, president and CEO said. "On behalf of our shareholders and the board of directors, I would like to thank our corporate and regional office employees, along with our Associates and their teams at store level, for their efforts and contributions to our collective success in 2013."
Commenting on the pending acquisition of the company by Loblaw, Pilla stated, "While the transaction must still be reviewed and approved by the Competition Bureau, we look forward to the conclusion of this process and the resultant combination of Canada’s leading food and pharmacy retailers."
Fiscal 2013 sales for the 52 weeks totaled C$11.06 billion compared with C$10.78 billion in 2012, an increase of 2.6%. On a same-store basis, sales increased 1.9% in 2013.
Pharmacy sales were C$5.23 billion in 2013 compared with C$5.10 billion in 2012, an increase of 2.5%, as strong growth in the number of prescriptions filled at retail, combined with further sales gains in the company’s MediSystem Technologies business, were partially offset by a further decline in average prescription value. On a same-store basis, pharmacy sales increased 1.3% during the year.
Front store sales were C$5.831 billion in 2013 compared with C$5.681 billion in 2012, an increase of $150 million or 2.6%, with the company posting sales gains in all categories, led by strong growth in cosmetics, OTC medications and food and confection. On a same-store basis, front store sales increased 2.5% in 2013.
Net earnings in 2013 were C$602 million compared with C$606 million in 2012. On a diluted basis, adjusted net earnings per share were C$3.05 in 2013 compared with C$2.97 in 2012, an increase of 2.7%.
During a conference call with analysts on Thursday, Pilla said the company plans on expanding its enhanced BeautyBOUTIQUE concept in 2014.
“Our enhanced beauty store at Bayview Village, which was our first prototype, is doing extremely well and continues on its momentum. And Eaton Centre, we are very pleased with the results at Eaton Centre … so we are anticipating building more of those starting in 2014,” Pilla said.
As previously reported, the company unveiled its second enhanced beautyBOUTIQUE at the Toronto Eaton Centre in August. The first enhanced BeautyBOUTIQUE opened in November 2012 in an existing Shoppers Drug Mart store in Bayview Village in Toronto.
With regard to its more traditional beautyBOUTIQUES, the company currently has 348 beautyBOUTIQUES, which includes 23 that were added in 2013.
“Our differentiated service model continues to resonate with Canadian consumers and so the quality, knowledge and passion of our beauty advisers is coming through. Therefore, that differentiated service offering, not only in terms of their service but all the unbiased service across all brands, seems to be the winning model in the Canadian consumers’ mind,” Pilla told analysts.
He added that the beauty advisers have been armed with tools, such as iPads, to offer shoppers more personalized service and further enhance the retailers’ differentiated service offering.
Report: Target exec apologizes for security breach in testimony
MINNEAPOLIS — John Mulligan, EVP and CFO of Target, said the retailer is deeply sorry for its late 2013 data security breach and is aware that consumer confidence in the company is shaken; his comments came during a Feb. 4 testimony before the Senate Judiciary Committee.
According to Reuters, Mulligan also said that Target discovered 25 registers infected with malware on Dec. 18, contradicting an earlier statement from the retailer that all malware had been removed by Dec. 15.
Mulligan also said Target is thoroughly reviewing the security of its payment network and issuing new cards to customers who request them. He said the Department of Justice initially informed Target of suspicious card activity on Dec. 12, and the company then investigated, removed malware and publicly announced the breach Dec. 19.
Senators on the committee said U.S. retailers need to adopt both chip-based payment cards and four-digit customer PINs to go with them. Mulligan said Target wants to switch to chip-and-PIN card payment, but so far banks have not supported the move. Committee chairman Patrick Leahy (D-Vt.) has proposed legislation to create a national standard for companies to report data breaches to the public, which has been endorsed by Federal Trade Commission chairwoman Edith Ramirez.
CVS Caremark supports AHA by participating in National Wear Red Day
WOONSOCKET, R.I. — CVS Caremark will participate in the American Heart Association’s National Wear Red Day on Feb. 7, by encouraging colleagues at 7,600 CVS/pharmacy locations nationwide to wear red and create awareness of the battle against heart disease in women.
CVS Caremark also will host heart-healthy education events for their colleagues across the country, and will make a $10,000 donation to the AHA in support of National Wear Red Day. For more than 10 years, the AHA has sponsored National Wear Red Day to raise awareness in the fight against heart disease in women.
"Heart disease continues to be the No. 1 killer of women in the United States," said Eileen Howard Boone, SVP corporate social responsibility and philanthropy for CVS Caremark and president of the CVS Caremark Charitable Trust. "Through these efforts, we can engage our colleagues in taking action against heart disease while supporting our purpose of helping people on their path to better health in the communities where we live and work."
For more information on the Go Red Campaign, and for heart healthy tools and resources, visit GoRedforWomen.org.